Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea
Improvement in Physical Functioning (SF-36 Activity Score) in COPD Patients With Exercise-induced Dyspnoea on Treatment With Spiriva® 18 Microgram (Capsules Containing 18 μg Tiotropium).
1 other identifier
observational
1,296
1 country
177
Brief Summary
This observational non-interventional study is designed to demonstrate the improvement of physical function in COPD patients with exercise-induced dyspnoea on treatment with Spiriva (tiotropium 18 µg capsules) and allows adverse events to be recorded and evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
177 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 21, 2007
CompletedFirst Posted
Study publicly available on registry
October 5, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2007
CompletedNovember 28, 2013
October 1, 2013
7 months
September 21, 2007
November 27, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
The primary endpoint was the proportion of patients with an improvement by ≥10 points in the standardised PF-10 score after 6 weeks of treatment with Spiriva® 18 Microgram
6 weeks
Secondary Outcomes (1)
The secondary endpoint was the change in the standardised PF-10 score within 6 weeks of treatment with Spiriva® 18 Microgram
6 weeks
Eligibility Criteria
patients of office-based pulmonology practices
You may qualify if:
- Men or women with COPD and a thoracic gas volume (TGV) of \< 140% at rest, MRC value of 2 or more.
You may not qualify if:
- Patients cannot be recruited if any of the general or specific contraindications listed in the Patient information leaflet or the Summary of Product Characteristics applies.
- Tiotropium bromide inhalation powder is contraindicated in patients with a hypersensitivity to tiotropium bromide, atropine or its derivatives, e.g. ipratropium or oxitropium or to the excipient lactose monohydrate which contains milk protein.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (177)
Boehringer Ingelheim Investigational Site
Amberg, Germany
Boehringer Ingelheim Investigational Site
Anklam, Germany
Boehringer Ingelheim Investigational Site
Aschau, Germany
Boehringer Ingelheim Investigational Site
Auerbach, Germany
Boehringer Ingelheim Investigational Site
Augsburg, Germany
Boehringer Ingelheim Investigational Site
Backnang, Germany
Boehringer Ingelheim Investigational Site
Bad Doberan, Germany
Boehringer Ingelheim Investigational Site
Bad Lippspringe, Germany
Boehringer Ingelheim Investigational Site
Bad Oeynhausen, Germany
Boehringer Ingelheim Investigational Site
Bad Soden, Germany
Boehringer Ingelheim Investigational Site
Bad Wörishofen, Germany
Boehringer Ingelheim Investigational Site
Beelitz, Germany
Boehringer Ingelheim Investigational Site
Bensheim, Germany
Boehringer Ingelheim Investigational Site
Bergisch Gladbach, Germany
Boehringer Ingelheim Investigational Site
Berlin, Germany
Boehringer Ingelheim Investigational Site
Biberach, Germany
Boehringer Ingelheim Investigational Site
Bochum, Germany
Boehringer Ingelheim Investigational Site
Bonn, Germany
Boehringer Ingelheim Investigational Site
Braunschweig, Germany
Boehringer Ingelheim Investigational Site
Breisach, Germany
Boehringer Ingelheim Investigational Site
Bremen, Germany
Boehringer Ingelheim Investigational Site
Bremerhaven, Germany
Boehringer Ingelheim Investigational Site
Bruchsal, Germany
Boehringer Ingelheim Investigational Site
Buchholz, Germany
Boehringer Ingelheim Investigational Site
Bünde, Germany
Boehringer Ingelheim Investigational Site
Calw, Germany
Boehringer Ingelheim Investigational Site
Castrop-Rauxel, Germany
Boehringer Ingelheim Investigational Site
Celle, Germany
Boehringer Ingelheim Investigational Site
Chemnitz, Germany
Boehringer Ingelheim Investigational Site
Coburg, Germany
Boehringer Ingelheim Investigational Site
Cologne, Germany
Boehringer Ingelheim Investigational Site
Cottbus, Germany
Boehringer Ingelheim Investigational Site
Darmstadt, Germany
Boehringer Ingelheim Investigational Site
Dillenburg, Germany
Boehringer Ingelheim Investigational Site
Dinslaken, Germany
Boehringer Ingelheim Investigational Site
Dortmund, Germany
Boehringer Ingelheim Investigational Site
Dresden, Germany
Boehringer Ingelheim Investigational Site
Duisburg, Germany
Boehringer Ingelheim Investigational Site
Düren, Germany
Boehringer Ingelheim Investigational Site
Düsseldorf, Germany
Boehringer Ingelheim Investigational Site
Eisenhüttenstadt, Germany
Boehringer Ingelheim Investigational Site
Emden, Germany
Boehringer Ingelheim Investigational Site
Erbach im Odenwald, Germany
Boehringer Ingelheim Investigational Site
Erfurt, Germany
Boehringer Ingelheim Investigational Site
Essen, Germany
Boehringer Ingelheim Investigational Site
Esslingen am Neckar, Germany
Boehringer Ingelheim Investigational Site
Euskirchen, Germany
Boehringer Ingelheim Investigational Site
Fellbach, Germany
Boehringer Ingelheim Investigational Site
Flensburg, Germany
Boehringer Ingelheim Investigational Site
Forchheim, Germany
Boehringer Ingelheim Investigational Site
Frankfurt, Germany
Boehringer Ingelheim Investigational Site
Freising, Germany
Boehringer Ingelheim Investigational Site
Fürstenfeldbruck, Germany
Boehringer Ingelheim Investigational Site
Fürth, Germany
Boehringer Ingelheim Investigational Site
Gadebusch, Germany
Boehringer Ingelheim Investigational Site
Geilenkirchen, Germany
Boehringer Ingelheim Investigational Site
Gelnhausen, Germany
Boehringer Ingelheim Investigational Site
Gelsenkirchen, Germany
Boehringer Ingelheim Investigational Site
Germering, Germany
Boehringer Ingelheim Investigational Site
Giessen, Germany
Boehringer Ingelheim Investigational Site
Gifhorn, Germany
Boehringer Ingelheim Investigational Site
Gotha, Germany
Boehringer Ingelheim Investigational Site
Göppingen, Germany
Boehringer Ingelheim Investigational Site
Greiz, Germany
Boehringer Ingelheim Investigational Site
Gummersbach, Germany
Boehringer Ingelheim Investigational Site
Gütersloh, Germany
Boehringer Ingelheim Investigational Site
Halberstadt, Germany
Boehringer Ingelheim Investigational Site
Halle, Germany
Boehringer Ingelheim Investigational Site
Hamburg, Germany
Boehringer Ingelheim Investigational Site
Hamelin, Germany
Boehringer Ingelheim Investigational Site
Hamm, Germany
Boehringer Ingelheim Investigational Site
Hanover, Germany
Boehringer Ingelheim Investigational Site
Heidelberg, Germany
Boehringer Ingelheim Investigational Site
Heilbronn, Germany
Boehringer Ingelheim Investigational Site
Herne, Germany
Boehringer Ingelheim Investigational Site
Hilden, Germany
Boehringer Ingelheim Investigational Site
Hildesheim, Germany
Boehringer Ingelheim Investigational Site
Hoyerswerda, Germany
Boehringer Ingelheim Investigational Site
Ibbenbueren, Germany
Boehringer Ingelheim Investigational Site
Ingolstadt, Germany
Boehringer Ingelheim Investigational Site
Iserlohn, Germany
Boehringer Ingelheim Investigational Site
Kaiserslautern, Germany
Boehringer Ingelheim Investigational Site
Kamen, Germany
Boehringer Ingelheim Investigational Site
Karlsruhe, Germany
Boehringer Ingelheim Investigational Site
Kaufbeuren, Germany
Boehringer Ingelheim Investigational Site
Kempten, Germany
Boehringer Ingelheim Investigational Site
Kevelaer, Germany
Boehringer Ingelheim Investigational Site
Kiel, Germany
Boehringer Ingelheim Investigational Site
Konstanz, Germany
Boehringer Ingelheim Investigational Site
Krefeld, Germany
Boehringer Ingelheim Investigational Site
Landshut, Germany
Boehringer Ingelheim Investigational Site
Langenfeld, Germany
Boehringer Ingelheim Investigational Site
Leipzig, Germany
Boehringer Ingelheim Investigational Site
Limburg, Germany
Boehringer Ingelheim Investigational Site
Lindenberg, Germany
Boehringer Ingelheim Investigational Site
Linz, Germany
Boehringer Ingelheim Investigational Site
Lippstadt, Germany
Boehringer Ingelheim Investigational Site
Loerrach, Germany
Boehringer Ingelheim Investigational Site
Ludwigsburg, Germany
Boehringer Ingelheim Investigational Site
Lüdenscheid, Germany
Boehringer Ingelheim Investigational Site
Lüneburg, Germany
Boehringer Ingelheim Investigational Site
Magdeburg, Germany
Boehringer Ingelheim Investigational Site
Mainz, Germany
Boehringer Ingelheim Investigational Site
Marburg, Germany
Boehringer Ingelheim Investigational Site
Markkleeberg, Germany
Boehringer Ingelheim Investigational Site
Memmingen, Germany
Boehringer Ingelheim Investigational Site
Menden, Germany
Boehringer Ingelheim Investigational Site
Minden, Germany
Boehringer Ingelheim Investigational Site
Moers, Germany
Boehringer Ingelheim Investigational Site
Mönchengladbach, Germany
Boehringer Ingelheim Investigational Site
Mühldorf, Germany
Boehringer Ingelheim Investigational Site
Mülheim, Germany
Boehringer Ingelheim Investigational Site
München, Germany
Boehringer Ingelheim Investigational Site
Neu-Ulm, Germany
Boehringer Ingelheim Investigational Site
Neunkirchen, Germany
Boehringer Ingelheim Investigational Site
Norderstedt, Germany
Boehringer Ingelheim Investigational Site
Nordhausen, Germany
Boehringer Ingelheim Investigational Site
Nuremberg, Germany
Boehringer Ingelheim Investigational Site
Oberursel, Germany
Boehringer Ingelheim Investigational Site
Olpe, Germany
Boehringer Ingelheim Investigational Site
Oschersleben, Germany
Boehringer Ingelheim Investigational Site
Osnabrück, Germany
Boehringer Ingelheim Investigational Site
Papenburg, Germany
Boehringer Ingelheim Investigational Site
Peine, Germany
Boehringer Ingelheim Investigational Site
Plauen, Germany
Boehringer Ingelheim Investigational Site
Potsdam, Germany
Boehringer Ingelheim Investigational Site
Pulheim, Germany
Boehringer Ingelheim Investigational Site
Rastatt, Germany
Boehringer Ingelheim Investigational Site
Rathenow, Germany
Boehringer Ingelheim Investigational Site
Regensburg, Germany
Boehringer Ingelheim Investigational Site
Remscheid, Germany
Boehringer Ingelheim Investigational Site
Rendsburg, Germany
Boehringer Ingelheim Investigational Site
Rostock, Germany
Boehringer Ingelheim Investigational Site
Rüdersdorf, Germany
Boehringer Ingelheim Investigational Site
Rüsselsheim am Main, Germany
Boehringer Ingelheim Investigational Site
Saarbrücken, Germany
Boehringer Ingelheim Investigational Site
Saarlouis, Germany
Boehringer Ingelheim Investigational Site
Salzgitter, Germany
Boehringer Ingelheim Investigational Site
Schenefeld, Germany
Boehringer Ingelheim Investigational Site
Schleswig, Germany
Boehringer Ingelheim Investigational Site
Schmölln, Germany
Boehringer Ingelheim Investigational Site
Schwalmstadt, Germany
Boehringer Ingelheim Investigational Site
Schwalmtal, Germany
Boehringer Ingelheim Investigational Site
Schwerin, Germany
Boehringer Ingelheim Investigational Site
Sebnitz, Germany
Boehringer Ingelheim Investigational Site
Seevetal, Germany
Boehringer Ingelheim Investigational Site
Siegen, Germany
Boehringer Ingelheim Investigational Site
Singen, Germany
Boehringer Ingelheim Investigational Site
Sinsheim, Germany
Boehringer Ingelheim Investigational Site
Solingen, Germany
Boehringer Ingelheim Investigational Site
Sonneberg, Germany
Boehringer Ingelheim Investigational Site
Spremberg, Germany
Boehringer Ingelheim Investigational Site
Stade, Germany
Boehringer Ingelheim Investigational Site
Starnberg, Germany
Boehringer Ingelheim Investigational Site
Steinbach, Germany
Boehringer Ingelheim Investigational Site
Straelen, Germany
Boehringer Ingelheim Investigational Site
Strausberg, Germany
Boehringer Ingelheim Investigational Site
Stuttgart, Germany
Boehringer Ingelheim Investigational Site
Teltow, Germany
Boehringer Ingelheim Investigational Site
Teterow, Germany
Boehringer Ingelheim Investigational Site
Troisdorf, Germany
Boehringer Ingelheim Investigational Site
Unna, Germany
Boehringer Ingelheim Investigational Site
Uttenreuth, Germany
Boehringer Ingelheim Investigational Site
Verden an der Aller, Germany
Boehringer Ingelheim Investigational Site
Waiblingen, Germany
Boehringer Ingelheim Investigational Site
Waren, Germany
Boehringer Ingelheim Investigational Site
Warendorf, Germany
Boehringer Ingelheim Investigational Site
Weiden, Germany
Boehringer Ingelheim Investigational Site
Weißenhorn, Germany
Boehringer Ingelheim Investigational Site
Wetzlar, Germany
Boehringer Ingelheim Investigational Site
Wiesloch, Germany
Boehringer Ingelheim Investigational Site
Wilhelmshaven, Germany
Boehringer Ingelheim Investigational Site
Witten, Germany
Boehringer Ingelheim Investigational Site
Worms, Germany
Boehringer Ingelheim Investigational Site
Wuppertal, Germany
Boehringer Ingelheim Investigational Site
Zella-Mehlis, Germany
Boehringer Ingelheim Investigational Site
Zossen, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Boehringer Ingelheim
Boehringer Ingelheim
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 21, 2007
First Posted
October 5, 2007
Study Start
April 1, 2007
Primary Completion
November 1, 2007
Last Updated
November 28, 2013
Record last verified: 2013-10